These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37592436)
1. Adverse reactions to cosmetic implants after COVID-19 vaccination: A literature review. Cheng WJ; Cai ZX; Tang XJ J Cosmet Dermatol; 2023 Dec; 22(12):3199-3212. PubMed ID: 37592436 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report. Michon A J Cosmet Dermatol; 2021 Sep; 20(9):2684-2690. PubMed ID: 34174156 [TBL] [Abstract][Full Text] [Related]
3. Potential immune response to breast implants after immunization with COVID-19 vaccines. Weitgasser L; Mahrhofer M; Schoeller T Breast; 2021 Oct; 59():76-78. PubMed ID: 34174765 [TBL] [Abstract][Full Text] [Related]
4. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles. Kalantari Y; Aryanian Z; Mirahmadi SM; Alilou S; Hatami P; Goodarzi A J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35534886 [TBL] [Abstract][Full Text] [Related]
5. Adverse reactions to cosmetic implants after COVID-19 vaccination: Correspondence. Kleebayoon A; Wiwanitkit V J Cosmet Dermatol; 2024 May; 23(5):1922. PubMed ID: 38192182 [No Abstract] [Full Text] [Related]
6. Side effects after COVID-19 vaccinations among residents of Poland. Andrzejczak-Grządko S; Czudy Z; Donderska M Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078 [TBL] [Abstract][Full Text] [Related]
7. Late inflammatory reactions in patients with soft tissue fillers after SARS-CoV-2 infection and vaccination: A systematic review of the literature. Bachour Y; Bekkenk MW; Rustemeyer T; Kadouch JA J Cosmet Dermatol; 2022 Apr; 21(4):1361-1368. PubMed ID: 35150192 [TBL] [Abstract][Full Text] [Related]
8. Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review. Wu Q; Zhang P; Zhou G; Fu Q; Bai R; Ding H; Meng F; Xu X; Chen M Aesthetic Plast Surg; 2024 Jun; 48(12):2343-2352. PubMed ID: 38302710 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2. Savva D; Battineni G; Amenta F; Nittari G Int J Infect Dis; 2021 Dec; 113():233-235. PubMed ID: 34597761 [TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older. Choi YY; Kim MK; Kwon HC; Kim GH J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers. Maruyama A; Sawa T; Teramukai S; Katoh N J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536 [TBL] [Abstract][Full Text] [Related]
14. Association between BNT162b2 vaccination and the development of delayed inflammatory reactions to hyaluronic acid-based dermal fillers-A nationwide survey. Safir A; Samuelov L; Sprecher E; Daniely D; Artzi O J Cosmet Dermatol; 2022 Oct; 21(10):4107-4113. PubMed ID: 35861599 [TBL] [Abstract][Full Text] [Related]
15. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021. Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study. Wang J; Hou Z; Liu J; Gu Y; Wu Y; Chen Z; Ji J; Diao S; Qiu Y; Zou S; Zhang A; Zhang N; Wang F; Li X; Wang Y; Liu X; Lv C; Chen S; Liu D; Ji X; Liu C; Ren T; Sun J; Zhao Z; Wu F; Li F; Wang R; Yan Y; Zhang S; Ge G; Shao J; Yang S; Liu C; Huang Y; Xu D; Li X; Ai J; He Q; Zheng MH; Zhang L; Xie Q; Rockey DC; Fallowfield JA; Zhang W; Qi X J Hepatol; 2021 Aug; 75(2):439-441. PubMed ID: 33905793 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study. Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid delayed inflammatory reaction after third dose of SARS-CoV-2 vaccine. Calvisi L J Cosmet Dermatol; 2022 Jun; 21(6):2315-2317. PubMed ID: 35384252 [TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836 [TBL] [Abstract][Full Text] [Related]
20. Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review. Kreuzberger N; Hirsch C; Andreas M; Böhm L; Bröckelmann PJ; Di Cristanziano V; Golinski M; Hausinger RI; Mellinghoff S; Lange B; Lischetzki T; Kappler V; Mikolajewska A; Monsef I; Park YS; Piechotta V; Schmaderer C; Stegemann M; Vanshylla K; Weber F; Weibel S; Stephani C; Skoetz N Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015021. PubMed ID: 35943061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]